AstraZeneca have expanded their collaboration with Cellectricon. AstraZeneca will install two Dynaflow high throughput ion channel screening systems.
Filed under: Ion Channel | Tagged: AstraZeneca, Cellectricon, Ion Channel, Research | Leave a Comment »
US and WO ion channel patents have been updated for this week at IonChannelCentral.com
Filed under: Uncategorized | Tagged: Ion Channel, patents | Leave a Comment »
US and WO ion channel patents have been updated for this week at IonChannelCentral.com
Filed under: Ion Channel | Tagged: Ion Channel, patents | Leave a Comment »
ICA-105665 KCNQ channel opener for epilepsy – Single ascending dose Phase I trial completed; multiple ascending dose Phase I initiated
Senicapoc for Asthma – Phase I trial initiated
Na and Ca channel Pain Program – Leads identified
Phase II trials for both projects expected in the second half of 2008
Filed under: Calcium Channel, Ion Channel, Potassium Channel, Sodium channel | Tagged: ca channel, Calcium Channel, ICA-17043, ICA17043, Icagen, Ion Channel, K Channel, KCNQ, na channel, Potassium Channel, Senicapoc, Sodium channel | Leave a Comment »
Vitamin D3 analog Elocalcitol has been found to upregulate Ca2+ entry through L-type Ca2+ channels. It may have a use in the modulation of bladder contractile mechanisms.
Filed under: Calcium Channel, Nuclear Receptor | Tagged: agonist, BioXell, BXL-628, BXL628, Elocalcitol, Ion Channel, L-type Ca channel | Leave a Comment »
A forthcoming Phase III trial of Clevidipine (Clevelox, Cleviprex) for Acute Hypertension and Intracerebral Hemorrhage is being carried out by The Medicines Company.
Filed under: Calcium Channel, Ion Channel | Tagged: ca channel, Calcium Channel, Clevelox, Clevidipine, Cleviprex, Ion Channel, The Medicines Company | Leave a Comment »
